My Account Log in

1 option

Clinical review report : indication : adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus inadequately controlled on basal insulin (less than 60 units daily) alone or in combination with metformin. Insulin glargine and lixisenatide injection (Soliqua) (Sanofi-Aventis) / Canadian Agency for Drugs and Technologies in Health.

NCBI Bookshelf Available online

View online
Format:
Book
Author/Creator:
Canadian Agency for Drugs and Technologies in Health, author, issuing body.
Language:
English
Subjects (All):
Drug interactions.
Outcome assessment (Medical care).
Physical Description:
1 online resource (118 pages) : illustrations
Edition:
Final (with redactions).
Place of Publication:
Canada : CADTH, 2019.
Summary:
The objective of this review is to perform a systematic review of the beneficial and harmful effects of iGlarLixi for the treatment of adults with T2DM inadequately controlled on basal insulin (alone or with metformin).
Notes:
Description based on publisher supplied metadata and other sources.

The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.

Find

Home Release notes

My Account

Shelf Request an item Bookmarks Fines and fees Settings

Guides

Using the Find catalog Using Articles+ Using your account